Logo image of CLI.MI

CENTRALE DEL LATTE D'ITALIA (CLI.MI) Stock Fundamental Analysis

Europe - Euronext Milan - BIT:CLI - IT0003023980 - Common Stock

4.76 EUR
-0.02 (-0.42%)
Last: 1/15/2026, 7:00:00 PM
Fundamental Rating

5

Taking everything into account, CLI scores 5 out of 10 in our fundamental rating. CLI was compared to 64 industry peers in the Food Products industry. While CLI is still in line with the averages on profitability rating, there are concerns on its financial health. CLI is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • CLI had positive earnings in the past year.
  • CLI had a positive operating cash flow in the past year.
  • Each year in the past 5 years CLI has been profitable.
  • Each year in the past 5 years CLI had a positive operating cash flow.
CLI.MI Yearly Net Income VS EBIT VS OCF VS FCFCLI.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

1.2 Ratios

  • The Return On Assets of CLI (3.87%) is comparable to the rest of the industry.
  • Looking at the Return On Equity, with a value of 14.51%, CLI is in the better half of the industry, outperforming 73.44% of the companies in the same industry.
  • With an excellent Return On Invested Capital value of 10.93%, CLI belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
  • CLI had an Average Return On Invested Capital over the past 3 years of 4.02%. This is below the industry average of 7.95%.
  • The last Return On Invested Capital (10.93%) for CLI is above the 3 year average (4.02%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.87%
ROE 14.51%
ROIC 10.93%
ROA(3y)0.98%
ROA(5y)1.12%
ROE(3y)3.7%
ROE(5y)4.3%
ROIC(3y)4.02%
ROIC(5y)3.66%
CLI.MI Yearly ROA, ROE, ROICCLI.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

  • CLI's Profit Margin of 1.91% is in line compared to the rest of the industry. CLI outperforms 43.75% of its industry peers.
  • In the last couple of years the Profit Margin of CLI has grown nicely.
  • The Operating Margin of CLI (3.48%) is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of CLI has grown nicely.
  • Looking at the Gross Margin, with a value of 19.91%, CLI is doing worse than 79.69% of the companies in the same industry.
  • In the last couple of years the Gross Margin of CLI has declined.
Industry RankSector Rank
OM 3.48%
PM (TTM) 1.91%
GM 19.91%
OM growth 3Y15.43%
OM growth 5YN/A
PM growth 3Y16.01%
PM growth 5YN/A
GM growth 3Y-0.63%
GM growth 5Y-14.6%
CLI.MI Yearly Profit, Operating, Gross MarginsCLI.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

3

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CLI is creating value.
  • Compared to 1 year ago, CLI has about the same amount of shares outstanding.
  • CLI has about the same amout of shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, CLI has a worse debt to assets ratio.
CLI.MI Yearly Shares OutstandingCLI.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
CLI.MI Yearly Total Debt VS Total AssetsCLI.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

  • CLI has an Altman-Z score of 2.59. This is not the best score and indicates that CLI is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of CLI (2.59) is better than 67.19% of its industry peers.
  • The Debt to FCF ratio of CLI is 5.46, which is a neutral value as it means it would take CLI, 5.46 years of fcf income to pay off all of its debts.
  • With a decent Debt to FCF ratio value of 5.46, CLI is doing good in the industry, outperforming 65.63% of the companies in the same industry.
  • A Debt/Equity ratio of 0.56 indicates that CLI is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.56, CLI perfoms like the industry average, outperforming 59.38% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 5.46
Altman-Z 2.59
ROIC/WACC2.09
WACC5.23%
CLI.MI Yearly LT Debt VS Equity VS FCFCLI.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

  • CLI has a Current Ratio of 0.86. This is a bad value and indicates that CLI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CLI has a worse Current ratio (0.86) than 78.13% of its industry peers.
  • CLI has a Quick Ratio of 0.86. This is a bad value and indicates that CLI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CLI's Quick ratio of 0.69 is on the low side compared to the rest of the industry. CLI is outperformed by 62.50% of its industry peers.
Industry RankSector Rank
Current Ratio 0.86
Quick Ratio 0.69
CLI.MI Yearly Current Assets VS Current LiabilitesCLI.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

5

3. Growth

3.1 Past

  • CLI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.22%, which is quite good.
  • The Earnings Per Share has been growing by 24.63% on average over the past years. This is a very strong growth
  • The Revenue has been growing slightly by 5.99% in the past year.
  • Measured over the past years, CLI shows a quite strong growth in Revenue. The Revenue has been growing by 14.83% on average per year.
EPS 1Y (TTM)15.22%
EPS 3Y24.63%
EPS 5YN/A
EPS Q2Q%-3.29%
Revenue 1Y (TTM)5.99%
Revenue growth 3Y7.26%
Revenue growth 5Y14.83%
Sales Q2Q%3.67%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.31% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 3.36% on average over the next years.
EPS Next Y-2.22%
EPS Next 2Y15.47%
EPS Next 3Y15.31%
EPS Next 5YN/A
Revenue Next Year8.24%
Revenue Next 2Y4.56%
Revenue Next 3Y3.36%
Revenue Next 5YN/A

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CLI.MI Yearly Revenue VS EstimatesCLI.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
CLI.MI Yearly EPS VS EstimatesCLI.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 0.6 0.8

8

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 6.61, the valuation of CLI can be described as very cheap.
  • Based on the Price/Earnings ratio, CLI is valued cheaply inside the industry as 95.31% of the companies are valued more expensively.
  • CLI is valuated cheaply when we compare the Price/Earnings ratio to 27.38, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 7.85, the valuation of CLI can be described as very cheap.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CLI indicates a rather cheap valuation: CLI is cheaper than 90.63% of the companies listed in the same industry.
  • CLI's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.29.
Industry RankSector Rank
PE 6.61
Fwd PE 7.85
CLI.MI Price Earnings VS Forward Price EarningsCLI.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • CLI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CLI is cheaper than 98.44% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CLI indicates a rather cheap valuation: CLI is cheaper than 96.88% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 4.37
EV/EBITDA 2.98
CLI.MI Per share dataCLI.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • CLI has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as CLI's earnings are expected to grow with 15.31% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.47%
EPS Next 3Y15.31%

0

5. Dividend

5.1 Amount

  • No dividends for CLI!.
Industry RankSector Rank
Dividend Yield 0%

CENTRALE DEL LATTE D'ITALIA

BIT:CLI (1/15/2026, 7:00:00 PM)

4.76

-0.02 (-0.42%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap66.64M
Revenue(TTM)522.24M
Net Income(TTM)9.99M
Analysts80
Price Target6.12 (28.57%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)5.26%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 6.61
Fwd PE 7.85
P/S 0.13
P/FCF 4.37
P/OCF 3.95
P/B 0.97
P/tB 1.35
EV/EBITDA 2.98
EPS(TTM)0.72
EY15.13%
EPS(NY)0.61
Fwd EY12.73%
FCF(TTM)1.09
FCFY22.88%
OCF(TTM)1.21
OCFY25.32%
SpS37.3
BVpS4.92
TBVpS3.53
PEG (NY)N/A
PEG (5Y)N/A
Graham Number8.93
Profitability
Industry RankSector Rank
ROA 3.87%
ROE 14.51%
ROCE 15.51%
ROIC 10.93%
ROICexc 17.78%
ROICexgc 24.39%
OM 3.48%
PM (TTM) 1.91%
GM 19.91%
FCFM 2.92%
ROA(3y)0.98%
ROA(5y)1.12%
ROE(3y)3.7%
ROE(5y)4.3%
ROIC(3y)4.02%
ROIC(5y)3.66%
ROICexc(3y)6.06%
ROICexc(5y)5.59%
ROICexgc(3y)8.01%
ROICexgc(5y)7.3%
ROCE(3y)5.7%
ROCE(5y)5.19%
ROICexgc growth 3Y32.21%
ROICexgc growth 5YN/A
ROICexc growth 3Y30.06%
ROICexc growth 5YN/A
OM growth 3Y15.43%
OM growth 5YN/A
PM growth 3Y16.01%
PM growth 5YN/A
GM growth 3Y-0.63%
GM growth 5Y-14.6%
F-Score7
Asset Turnover2.02
Health
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 5.46
Debt/EBITDA 1.12
Cap/Depr 10.1%
Cap/Sales 0.31%
Interest Coverage 5.37
Cash Conversion 49.27%
Profit Quality 152.57%
Current Ratio 0.86
Quick Ratio 0.69
Altman-Z 2.59
F-Score7
WACC5.23%
ROIC/WACC2.09
Cap/Depr(3y)17.55%
Cap/Depr(5y)36.42%
Cap/Sales(3y)0.86%
Cap/Sales(5y)2.07%
Profit Quality(3y)1366.96%
Profit Quality(5y)1110.01%
High Growth Momentum
Growth
EPS 1Y (TTM)15.22%
EPS 3Y24.63%
EPS 5YN/A
EPS Q2Q%-3.29%
EPS Next Y-2.22%
EPS Next 2Y15.47%
EPS Next 3Y15.31%
EPS Next 5YN/A
Revenue 1Y (TTM)5.99%
Revenue growth 3Y7.26%
Revenue growth 5Y14.83%
Sales Q2Q%3.67%
Revenue Next Year8.24%
Revenue Next 2Y4.56%
Revenue Next 3Y3.36%
Revenue Next 5YN/A
EBIT growth 1Y1.62%
EBIT growth 3Y23.81%
EBIT growth 5YN/A
EBIT Next Year133.78%
EBIT Next 3Y38.93%
EBIT Next 5YN/A
FCF growth 1Y24.28%
FCF growth 3Y-17.37%
FCF growth 5YN/A
OCF growth 1Y17.37%
OCF growth 3Y-18.49%
OCF growth 5Y10.4%

CENTRALE DEL LATTE D'ITALIA / CLI.MI FAQ

What is the ChartMill fundamental rating of CENTRALE DEL LATTE D'ITALIA (CLI.MI) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CLI.MI.


What is the valuation status of CENTRALE DEL LATTE D'ITALIA (CLI.MI) stock?

ChartMill assigns a valuation rating of 8 / 10 to CENTRALE DEL LATTE D'ITALIA (CLI.MI). This can be considered as Undervalued.


How profitable is CENTRALE DEL LATTE D'ITALIA (CLI.MI) stock?

CENTRALE DEL LATTE D'ITALIA (CLI.MI) has a profitability rating of 6 / 10.


What is the valuation of CENTRALE DEL LATTE D'ITALIA based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CENTRALE DEL LATTE D'ITALIA (CLI.MI) is 6.61 and the Price/Book (PB) ratio is 0.97.


What is the earnings growth outlook for CENTRALE DEL LATTE D'ITALIA?

The Earnings per Share (EPS) of CENTRALE DEL LATTE D'ITALIA (CLI.MI) is expected to decline by -2.22% in the next year.